be critical to prevent attachment of pathogen. BF production increased or remained unchanged in the presence of amikacin. Due to toxicity concerns and variation in resistance patterns, minocycline is a viable treatment option against A. baumannii. Additional studies are warranted. Disclosures. K. LaPlante, Merck: Grant Investigator, Grant recipient. Pfizer: Grant Investigator, Grant recipient. ...
